Avalo Therapeutics (NASDAQ:AVTX) Upgraded to Strong-Buy at Wedbush
Wedbush upgraded shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) to a strong-buy rating in a research report released on Thursday,Zacks.com reports. A number of other equities research analysts also recently commented on AVTX. BTIG Research assumed coverage on Avalo Therapeutics in a report on Thursday, December 19th. They issued a “buy” rating and a […]
Wedbush upgraded shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) to a strong-buy rating in a research report released on Thursday,Zacks.com reports. A number of other equities research analysts also recently commented on AVTX. BTIG Research assumed coverage on Avalo Therapeutics in a report on Thursday, December 19th. They issued a “buy” rating and a […]
